Gene Editing In-Vitro In-Vivo Life Science 
Drug Discovery World
NOVEMBER 16, 2022
In April 2021, life sciences solutions provider Molecular Devices launched its Organoid Innovation Centre (OIC), an initiative designed to help scientists leverage the potential of 3D biology throughout the drug discovery process. . 2D vs 3D . 2D biology has been used by pharmaceutical researchers for decades.
Drug Discovery World
APRIL 3, 2023
As life science operates globally, the vision for the business was always to bring aptamers as an antibody alternative to researchers worldwide. What advice would you offer to similar start-ups? AT: Integral to Aptamer Group’s offering is an in-depth understanding of molecular science.
Expert insights. Personalized for you.
97 
Let's personalize your content